Dr. Sarah Ferguson

• 2024–present; Vice Chair of Research, Department of Obstetrics and Gynecology, University of Toronto, Toronto
• 2024–present; Head of Research, Department of Obstetrics and Gynecology at Sinai Health/University Health Network/Women’s College Hospital, Toronto
• 2020–present; Professor, Division of Gynaecologic Oncology and Surgical Oncology, Obstetrics and Gynaecology, University of Toronto, Toronto
• 2019–present; Clinician Investigator, Princess Margaret Cancer Centre Research Institute, University Health Network, Toronto
• 2017–present; J. Douglas Crashley Chair in Gynaecologic Cancer Research, University Health Network, Toronto
• 2016–present; Associate Member of the Institute of Medical Science, University of Toronto, Toronto
• 2016–present; Lead of Research, Division of Gynecologic Oncology, University of Toronto, Toronto
• 2015–present; Associate Scientist, Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto
• 2012–present; Director of Gynaecologic Oncology Research Program, Division of Gynaecologic Oncology, University Health Network, Princess Margaret Hospital, Toronto
• 2011–present; Consultant Gynaecologic Oncologist, Zane Cohen Centre for Digestive Disease, Mount Sinai Hospital, Sinai Health, Toronto

Former appointments

• 2021–2023; Member, University of Toronto, Faculty of Medicine Decanal Committee, Toronto
• 2017–2025; Ontario Gynecologic Cancers Lead, Ontario Health/Cancer Care Ontario
• 2017–2025; Chair, Ontario Gynecologic Drug Advisory Committee
   

• Clinical Fellow in Gynecologic Oncology, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; 2002–2006 
• Resident, Department of Obstetrics and Gynecology, University of Toronto, Toronto; 1997–2002 
• MD (Honours), Queen’s University School of Medicine, Kingston, Canada; 1993–1997 
• BSc (Honours), Queen’s University School of Medicine, Kingston, Canada; 1989–1993 

• 2024 – 2023–2024 Chair’s Award for Excellence in Research Facilitation, Department of Obstetrics and Gynecology, University of Toronto, Toronto. This Award is presented to a faculty member who has demonstrated leadership and sustained commitment to participation in clinical research in the field of Obstetrics & Gynaecology.
• 2022–2024 – Merit Award, Department of Obstetrics and Gynecology, University of Toronto, Toronto, (Research Award, Specialty: Personalized Liquid Biopsy (circulating tumor DNA) to Monitor Response to Fertility-Sparing Treatment in People with Endometrial Cancer)
• 2022–2023 – Award for Teaching Excellence in recognition of your contribution to the Undergraduate Education program in the Department of Obstetrics and Gynaecology at Princess Margaret Cancer Centre, Toronto
• 2022–2023 – Teaching Award for Excellence in recognition by the students of the MD program for exemplifying excellence in undergraduate medical education 
• 2020–2022 – Merit Award, Department of Obstetrics and Gynecology, University of Toronto, Toronto, (Research Award, Specialty: Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Low Grade Cancer of the Endometrium)
• 2020 – The Society of Gynecologic Oncology (SGO) Presidential Award, Sentinel Lymph Node Biopsy Versus Lymphadenectomy for High-Grade Endometrial Cancer Staging (SENTOR Trial): A Prospective Multicenter Cohort Study
• 2018–2020 – Merit Award, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada, (Research Award. Specialty: Targeting the Immune Microenvironment of Microsatellite Instable Non-Serous Ovarian Carcinoma)
• 2018 – Chair’s Award for Sustained Research Excellence, Department of Obstetrics and Gynecology, University of Toronto, Toronto. Award recognizing an individual who has demonstrated sustained excellence in research in the field of Obstetrics and Gynaecology. 
• 2011 – Ovarian Cancer Canada Award in Support of Psychosocial Oncology Excellence, Canadian Association of Psychosocial Oncology